Literature DB >> 11968051

Comparison of four enzyme immunoassays for the detection of immunoglobulin G antibody against glomerular basement membrane.

Troy D Jaskowski1, Thomas B Martins, Christine M Litwin, Harry R Hill.   

Abstract

Goodpasture syndrome is a life-threatening autoimmune kidney and pulmonary disease that is characterized by pulmonary hemorrhage, renal failure, and the presence of autoantibodies against glomerular basement membrane (GBM) by indirect fluorescent antibody (IFA) techniques. In 1988, these antibodies were found to be specific for the noncollagen region of the alpha3 collagen IV chain. The antigen is characterized by a restricted tissue distribution occurring mainly in the kidneys and lungs. Specific enzyme immunoassays (EIAs) for anti-GBM have now been developed for in vitro diagnostic use in the laboratory. Our objective in this study was to compare the results obtained using four different EIAs for detecting anti-GBM IgG antibody with those using the standard IFA method using tissue from human kidney. Thirty-two patients with suspected Goodpasture syndrome, and 10 control sera were included in the study. GBM EIAs were purchased from or donated by the following vendors: Scimedx Corporation (Denville, NJ), INOVA Diagnostics (San Diego, CA), The Binding Site (Birmingham, England), and Wieslab (distributed by DiaSorin, Inc., Stillwater, MN). Percent agreement, sensitivity, and specificity were calculated for each EIA as compared to IFA. The results were as follows: Binding Site: 83.3, 100.0, and 72.0%; Wieslab: 95.2, 94.1, and 96.0%; INOVA: 96.2, 100.0, and 92.3%; and Scimedx: 81.0, 100.0, and 68.0%. We conclude that the INOVA and Wieslab GBM IgG EIAs compared well with the standard GBM IFA method using tissue from human kidney. The Scimedx and Binding Site EIAs had eight and seven false-positive results, respectively, when compared to GBM IFA using human kidney. The authors recommend conducting thorough evaluations of EIAs that screen for anti-GBM antibody before their implementation in the clinical laboratory. We also recommend confirming GBM EIA-positive sera by the standard IFA method using tissue from human kidney. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11968051      PMCID: PMC6807879          DOI: 10.1002/jcla.10034

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  10 in total

1.  Hereditary nephritis: immunoblotting studies of the glomerular basement membrane.

Authors:  C O Savage; L H Noel; E Crutcher; S R Price; J P Grunfeld; C M Lockwood
Journal:  Lab Invest       Date:  1989-05       Impact factor: 5.662

Review 2.  The Goodpasture antigen.

Authors:  J Wieslander
Journal:  Contrib Nephrol       Date:  1990       Impact factor: 1.580

3.  Distribution of Goodpasture antigens within various human basement membranes.

Authors:  M Weber; O Pullig; H Köhler
Journal:  Nephrol Dial Transplant       Date:  1990       Impact factor: 5.992

4.  [Immuno-histological characterization of glomerular nephropathies evaluated by direct and indirect methods].

Authors:  A Tarantino; G Barbiano di Belgiojoso; A Durante; E Imbasciati; C Bazzi
Journal:  Minerva Nefrol       Date:  1973 Jul-Oct

5.  [Immunologic diagnosis of glomerulonephritis by basement membrane antibodies].

Authors:  W Schneider; T Manger; T Porstmann
Journal:  Z Urol Nephrol       Date:  1986-02

6.  Tissue-specific distribution of the Goodpasture antigen demonstrated by 2-D electrophoresis and western blotting.

Authors:  C J Derry; C D Pusey
Journal:  Nephrol Dial Transplant       Date:  1994       Impact factor: 5.992

7.  Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV.

Authors:  J Saus; J Wieslander; J P Langeveld; S Quinones; B G Hudson
Journal:  J Biol Chem       Date:  1988-09-15       Impact factor: 5.157

8.  Antineutrophil-cytoplasmic antibodies and antiglomerular basement membrane antibodies in Goodpasture's syndrome and in Wegener's granulomatosis.

Authors:  M F Weber; K Andrassy; O Pullig; J Koderisch; K Netzer
Journal:  J Am Soc Nephrol       Date:  1992-01       Impact factor: 10.121

Review 9.  Pulmonary-renal syndromes.

Authors:  K R Young
Journal:  Clin Chest Med       Date:  1989-12       Impact factor: 2.878

10.  Pulmonary renal syndromes--a review.

Authors:  R A Matthay; S I Bromberg; C E Putman
Journal:  Yale J Biol Med       Date:  1980 Nov-Dec
  10 in total
  6 in total

1.  Alveolar haemorrhage in anti-glomerular basement membrane disease without detectable antibodies by conventional assays.

Authors:  D J Serisier; R C W Wong; J G Armstrong
Journal:  Thorax       Date:  2006-07       Impact factor: 9.139

2.  Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease.

Authors:  Stephen W Olson; Charles B Arbogast; Thomas P Baker; David Owshalimpur; David K Oliver; Kevin C Abbott; Christina M Yuan
Journal:  J Am Soc Nephrol       Date:  2011-08-25       Impact factor: 10.121

3.  Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies in vivo in Severe Kidney Disease: An Open-Label Phase 2a Study.

Authors:  Fredrik Uhlin; Wladimir Szpirt; Andreas Kronbichler; Annette Bruchfeld; Inga Soveri; Lionel Rostaing; Eric Daugas; Arnaud Lionet; Nassim Kamar; Cédric Rafat; Marek Mysliveček; Vladimír Tesař; Anders Fernström; Christian Kjellman; Charlotte Elfving; Stephen McAdoo; Johan Mölne; Ingeborg Bajema; Elisabeth Sonesson; Mårten Segelmark
Journal:  J Am Soc Nephrol       Date:  2022-03-08       Impact factor: 14.978

4.  Absence of Anti-Glomerular Basement Membrane Antibodies in 200 Patients With Systemic Lupus Erythematosus With or Without Lupus Nephritis: Results of the GOODLUPUS Study.

Authors:  Nellie Bourse Chalvon; Pauline Orquevaux; Delphine Giusti; Gregory Gatouillat; Thierry Tabary; Marcelle Tonye Libyh; Jan Chrusciel; Moustapha Drame; Grace Stockton-Bliard; Zahir Amoura; Laurent Arnaud; Hanns-Martin Lorenz; Gilles Blaison; Bernard Bonnotte; Nadine Magy-Bertrand; Sabine Revuz; Reinhard Edmund Voll; Oliver Hinschberger; Andreas Schwarting; Bach Nga Pham; Thierry Martin; Jean-Loup Pennaforte; Amelie Servettaz
Journal:  Front Immunol       Date:  2020-12-14       Impact factor: 7.561

5.  An Unusual Case of Anti-GBM Antibody Elevation in HIV-Associated Nephropathy.

Authors:  Vinay Minocha; Raafat Makary; Andreea Poenariu
Journal:  Case Rep Nephrol       Date:  2014-06-03

6.  Frequently relapsing anti-glomerular basement membrane antibody disease with changing clinical phenotype and antibody characteristics over time.

Authors:  Bobby Gu; Alex B Magil; Sean J Barbour
Journal:  Clin Kidney J       Date:  2016-06-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.